Axsome Therapeutics, Inc.

Axsome Therapeutics is a U.S. biopharmaceutical company developing and commercializing medicines for central nervous system disorders. Its research focuses on pharmacological interventions for neurological and psychiatric conditions, supported by clinical development and commercialization operations. The company's therapeutic interests include disorders affecting mood, cognition, sleep and related neural functions. Axsome is headquartered in New York and its shares are listed on Nasdaq under AXSM. Its work spans the identification of treatment approaches, clinical assessment of therapies and delivery of medicines to patients with neurological or psychiatric needs. This combination of research and commercial capabilities defines its biopharmaceutical operating model.